Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.

被引：0
|
作者：
Cramer, EM [1 ]
Moers, C [1 ]
Zarghooni, V [1 ]
Mallmann, P [1 ]
Warm, M [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：82S / 82S
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [2] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [3] Neoadjuvant dose-dense sequential biweekly epirubicin and cyclophosphamide followed by docetaxel and trastuzumab for HER2+operable breast cancer
    Blakely, L.
    Somer, B.
    Keaton, M.
    Hermann, R.
    Schnell, F.
    Cobb, P.
    Johns, A.
    Walker, M.
    Schwartzberg, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Neoadjuvant biweekly dose-dense chemotherapy with fluouracil, epirubicin, and cyclophosphamide (FEC 90), followed by docetaxel in patients with HER2-neu negative primary breast cancer
    Rodriguez-Abreu, D.
    Murias, A.
    Garcia, M.
    Vega, V.
    Garcia, C.
    Mori, M.
    Baez-Acosta, B.
    Diez, A.
    Almenarez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer
    Grassadonia, Antonino
    Cianchetti, Ettore
    Ficorella, Corrado
    Angelucci, Domenico
    Grossi, Simona
    Ricevuto, Enrico
    Zilli, Marinella
    Tinari, Nicola
    Natoli, Clara
    Iacobelli, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
  • [6] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [7] Primary dose-dense epirubicin/cyclophosphamide→docetaxel in breast cancer: preliminary results
    Cocciolone, V.
    Cannita, K.
    Bruera, G.
    Bafile, A.
    Coletti, G.
    Resta, V.
    Ciccozzi, A.
    Dalmas, A.
    Ficorella, C.
    Ricevuto, E.
    BREAST, 2015, 24 : S100 - S101
  • [8] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Xinguang Wang
    Yingjian He
    Tianfeng Wang
    Yuntao Xie
    Jinfeng Li
    Tao Ouyang
    Zhaoqing Fan
    Supportive Care in Cancer, 2019, 27 : 3019 - 3025
  • [9] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Wang, Xinguang
    He, Yingjian
    Wang, Tianfeng
    Xie, Yuntao
    Li, Jinfeng
    Ouyang, Tao
    Fan, Zhaoqing
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3019 - 3025
  • [10] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
12345